p38 mitogen-activated kinase (MAPK) is essential for equine neutrophil migration

Veterinary Immunology and Immunopathology

Volumn 129, Issue 3-4, 2009, Pages 181-191

  Eckert, Rachael E ^a   Sharief, Yousuf ^a   Jones, Samuel L ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Inflammation; Laminitis; Other animals

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; NEUTROPHIL; NONHUMAN;

ANIMALS; ANTIGENS, CD18; CELL ADHESION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HORSES; IMIDAZOLES; INFLAMMATION; LEUKOTRIENE B4; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES;

ANIMALIA; EQUIDAE;

EID: 64749093057     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.11.007     Document Type: Article

References (90)

1. Adair III H.S., Goble D.O., Schmidhammer J.L., and Shires G.M. Laminar microvascular flow, measured by means of laser Doppler flowmetry, during the prodromal stages of black walnut-induced laminitis in horses. Am. J. Vet. Res. 61 (2000) 862-868
2. Alvarado-Kristensson M., Porn-Ares M.I., Grethe S., Smith D., Zheng L., and Andersson T. p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase activities have opposite effects on human neutrophil apoptosis. FASEB J. 16 (2002) 129-131
3. Anderson D.C., Miller L.J., Schmalstieg F.C., Rothlein R., and Springer T.A. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies. J. Immunol. 137 (1986) 15-27
4. Badger A.M., Bradbeer J.N., Votta B., Lee J.C., Adams J.L., and Griswold D.E. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279 (1996) 1453-1461
5. Bailey S.R., Marr C.M., and Elliott J. Current research and theories on the pathogenesis of acute laminitis in the horse. Vet. J. 167 (2004) 129-142
6. Belknap J.K., Giguere S., Pettigrew A., Cochran A.M., Van Eps A.W., and Pollitt C.C. Lamellar pro-inflammatory cytokine expression patterns in laminitis at the developmental stage and at the onset of lameness: innate vs. adaptive immune response. Equine Vet. J. 39 (2007) 42-47
7. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., and Engler J.A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4 (1993) 197-250
8. Black S.J., Lunn D.P., Yin C., Hwang M., Lenz S.D., and Belknap J.K. Leukocyte emigration in the early stages of laminitis. Vet. Immunol. Immunopathol. 109 (2006) 161-166
9. Blikslager A.T., Yin C., Cochran A.M., Wooten J.G., Pettigrew A., and Belknap J.K. Cyclooxygenase expression in the early stages of equine laminitis: a cytologic study. J. Vet. Intern. Med. 20 (2006) 1191-1196
10. Borregaard N., Kjeldsen L., Sengelov H., Diamond M.S., Springer T.A., Anderson H.C., Kishimoto T.K., and Bainton D.F. Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J. Leukoc. Biol. 56 (1994) 80-87
11. Bottoms G.D., and Adams H.R. Involvement of prostaglandins and leukotrienes in the pathogenesis of endotoxemia and sepsis. J. Am. Vet. Med. Assoc. 200 (1992) 1842-1848
12. Brady C.A., and Otto C.M. Systemic inflammatory response syndrome, sepsis, and multiple organ dysfunction. Vet. Clin. North Am. Small Anim. Pract. 31 (2001) 1147-1211
13. Branger J., van den B.B., Weijer S., Madwed J., Bos C.L., Gupta A., Yong C.L., Polmar S.H., Olszyna D.P., Hack C.E., van Deventer S.J., Peppelenbosch M.P., and van der P.T. Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J. Immunol. 168 (2002) 4070-4077
14. Branger J., van den B.B., Weijer S., Gupta A., van Deventer S.J., Hack C.E., Peppelenbosch M.P., and van der P.T. Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. Blood 101 (2003) 4446-4448
15. Brooks A.C., Menzies-Gow N.J., Wheeler-Jones C., Bailey S.R., Cunningham F.M., and Elliott J. Endotoxin-induced activation of equine platelets: evidence for direct activation of p38 MAPK pathways and vasoactive mediator production. Inflamm. Res. 56 (2007) 154-161
16. Cara D.C., Kaur J., Forster M., McCafferty D.M., and Kubes P. Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo. J. Immunol. 167 (2001) 6552-6558
17. Cripps P.J., and Eustace R.A. Factors involved in the prognosis of equine laminitis in the UK. Equine Vet. J. 31 (1999) 433-442
18. Dauphinee S.M., and Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab Invest. 86 (2006) 9-22
19. Eckert R.E., Neuder L.E., Bell J.L., Trujillo J.C., and Jones S.L. The role of p38 mitogen-activated kinase (MAPK) in the mechanism regulating cyclooxygenase gene expression in equine leukocytes. Vet. Immunol. Immunopathol. 118 (2007) 294-303
20. Faure E., Equils O., Sieling P.A., Thomas L., Zhang F.X., Kirschning C.J., Polentarutti N., Muzio M., and Arditi M. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275 (2000) 11058-11063
21. Faurschou M., and Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5 (2003) 1317-1327
22. Fijen J.W., Zijlstra J.G., De Boer P., Spanjersberg R., Tervaert J.W., Van Der Werf T.S., Ligtenberg J.J., and Tulleken J.E. Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers. Clin. Exp. Immunol. 124 (2001) 16-20
23. Fontaine G.L., Belknap J.K., Allen D., Moore J.N., and Kroll D.L. Expression of interleukin-1beta in the digital laminae of horses in the prodromal stage of experimentally induced laminitis. Am. J. Vet. Res. 62 (2001) 714-720
24. French K.R., and Pollitt C.C. Equine laminitis: cleavage of laminin 5 associated with basement membrane dysadhesion. Equine Vet. J. 36 (2004) 242-247
25. Galey F.D., Whiteley H.E., Goetz T.E., Kuenstler A.R., Davis C.A., and Beasley V.R. Black walnut (Juglans nigra) toxicosis: a model for equine laminitis. J. Comp. Pathol. 104 (1991) 313-326
26. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 13 (2001) 85-94
27. Hannigan M., Zhan L., Ai Y., and Huang C.K. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils. Biochem. Biophys. Res. Commun. 246 (1998) 55-58
28. Hannigan M.O., Zhan L., Ai Y., Kotlyarov A., Gaestel M., and Huang C.K. Abnormal migration phenotype of mitogen-activated protein kinase-activated protein kinase 2-/- neutrophils in Zigmond chambers containing formyl-methionyl-leucyl-phenylalanine gradients. J. Immunol. 167 (2001) 3953-3961
29. Heit B., Tavener S., Raharjo E., and Kubes P. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159 (2002) 91-102
30. Heuertz R.M., Tricomi S.M., Ezekiel U.R., and Webster R.O. C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement. J. Biol. Chem. 274 (1999) 17968-17974
31. Hickstein D.D., Ozols J., Williams S.A., Baenziger J.U., Locksley R.M., and Roth G.J. Isolation and characterization of the receptor on human neutrophils that mediates cellular adherence. J. Biol. Chem. 262 (1987) 5576-5580
32. Hijiya N., Miyake K., Akashi S., Matsuura K., Higuchi Y., and Yamamoto S. Possible involvement of toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide. Pathobiology 70 (2002) 18-25
33. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., Sozzani S., Mantovani A., Altruda F., and Wymann M.P. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287 (2000) 1049-1053
34. Hood D.M. Laminitis as a systemic disease. Vet. Clin. North Am. Equine Pract. 15 (1999) 481-494 viii
35. Hood D.M., Grosenbaugh D.A., Mostafa M.B., Morgan S.J., and Thomas B.C. The role of vascular mechanisms in the development of acute equine laminitis. J. Vet. Intern. Med. 7 (1993) 228-234
36. Hood D.M., Wagner I.P., and Brumbaugh G.W. Evaluation of hoof wall surface temperature as an index of digital vascular perfusion during the prodromal and acute phases of carbohydrate-induced laminitis in horses. Am. J. Vet. Res. 62 (2001) 1167-1172
37. Huang C.K., Zhan L., Ai Y., and Jongstra J. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J. Biol. Chem. 272 (1997) 17-19
38. Huang C., Jacobson K., and Schaller M.D. MAP kinases and cell migration. J. Cell Sci. 117 (2004) 4619-4628
39. Hunt R.J. A retrospective evaluation of laminitis in horses. Equine Vet. J. 25 (1993) 61-64
40. Hurley D.J., Parks R.J., Reber A.J., Donovan D.C., Okinaga T., Vandenplas M.L., Peroni J.F., and Moore J.N. Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract. Vet. Immunol. Immunopathol. 110 (2006) 195-206
41. Jones S.L., and Sharief Y. Asymmetrical protein kinase A activity establishes neutrophil cytoskeletal polarity and enables chemotaxis. J. Leukoc. Biol. 78 (2005) 248-258
42. Jongstra-Bilen J., Janmey P.A., Hartwig J.H., Galea S., and Jongstra J. The lymphocyte-specific protein LSP1 binds to F-actin and to the cytoskeleton through its COOH-terminal basic domain. J. Cell Biol. 118 (1992) 1443-1453
43. Keller H.U., and Niggli V. Selective effects of the PKC inhibitors Ro 31-8220 and CGP, 41, 251 on PMN locomotion, cell polarity, and pinocytosis. J. Cell Physiol. 161 (1994) 526-536
44. Kitamura H., Kanehira K., Okita K., Morimatsu M., and Saito M. MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production. FEBS Lett. 485 (2000) 53-56
45. Knall C., Worthen G.S., Buhl A.M., and Johnson G.L. IL-8 signal transduction in human neutrophils. Ann. N. Y. Acad. Sci. 766 (1995) 288-291
46. Krump E., Sanghera J.S., Pelech S.L., Furuya W., and Grinstein S. Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J. Biol. Chem. 272 (1997) 937-944
47. Laudanna C., and Alon R. Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes. Thromb. Haemost. 95 (2006) 5-11
48. Laudanna C., Kim J.Y., Constantin G., and Butcher E. Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 186 (2002) 37-46
49. Loftus J.P., Belknap J.K., and Black S.J. Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance. Vet. Immunol. Immunopathol. 113 (2006) 267-276
50. Lokuta M.A., and Huttenlocher A. TNF-alpha promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway. J. Leukoc. Biol. 78 (2005) 210-219
51. Magder S., Neculcea J., Neculcea V., and Sladek R. Lipopolysaccharide and TNF-alpha produce very similar changes in gene expression in human endothelial cells. J. Vasc. Res. 43 (2006) 447-461
52. Menzies-Gow N.J., Bailey S.R., Katz L.M., Marr C.M., and Elliott J. Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Equine Vet. J. 36 (2004) 273-278
53. Montrucchio G., Bosco O., Del Sorbo L., Fascio P.P., Lupia E., Goffi A., Omede P., Emanuelli G., and Camussi G. Mechanisms of the priming effect of low doses of lipopolysaccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb. Haemost. 90 (2003) 872-881
54. Moore J.N., and Barton M.H. An update on endotoxemia. Part I: mechanisms and pathways. 145. Equine Vet. Educ. 10 (1998) 300-306
55. Morris D.D., Crowe N., and Moore J.N. Correlation of clinical and laboratory data with serum tumor necrosis factor activity in horses with experimentally induced endotoxemia. Am. J. Vet. Res. 51 (1990) 1935-1940
56. Nick J.A., Avdi N.J., Young S.K., Knall C., Gerwins P., Johnson G.L., and Worthen G.S. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest. 99 (1997) 975-986
57. Nick J.A., Young S.K., Arndt P.G., Lieber J.G., Suratt B.T., Poch K.R., Avdi N.J., Malcolm K.C., Taube C., Henson P.M., and Worthen G.S. Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J. Immunol. 169 (2002) 5260-5269
58. Ono K., and Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 12 (2000) 1-13
59. Parrillo J.E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328 (1993) 1471-1477
60. Parsons C.S., Orsini J.A., Krafty R., Capewell L., and Boston R. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004). J. Am. Vet. Med. Assoc. 230 (2007) 885-889
61. Peloso J.G., Cohen N.D., Walker M.A., Watkins J.P., Gayle J.M., and Moyer W. Case-control study of risk factors for the development of laminitis in the contralateral limb in Equidae with unilateral lameness. J. Am. Vet. Med. Assoc. 209 (1996) 1746-1749
62. Peng T., Lu X., Lei M., Moe G.W., and Feng Q. Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia. Cardiovasc. Res. 59 (2003) 893-900
63. Pollitt C.C. Basement membrane pathology: a feature of acute equine laminitis. Equine Vet. J. 28 (1996) 38-46
64. Pollitt C.C., Pass M.A., and Pollitt S. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis. Equine Vet. J. Suppl. (1998) 119-124
65. Prasse K.W., Allen Jr. D., Moore J.N., and Duncan A. Evaluation of coagulation and fibrinolysis during the prodromal stages of carbohydrate-induced acute laminitis in horses. Am. J. Vet. Res. 51 (1990) 1950-1955
66. Remer K.A., Brcic M., and Jungi T.W. Toll-like receptor-4 is involved in eliciting an LPS-induced oxidative burst in neutrophils. Immunol. Lett. 85 (2003) 75-80
67. Rodgerson D.H., Belknap J.K., Moore J.N., and Fontaine G.L. Investigation of mRNA expression of tumor necrosis factor-alpha, interleukin-1beta, and cyclooxygenase-2 in cultured equine digital artery smooth muscle cells after exposure to endotoxin. Am. J. Vet. Res. 62 (2001) 1957-1963
68. Roos F.J., Zimmermann A., and Keller H.U. Effect of phorbol myristate acetate and the chemotactic peptide fNLPNTL on shape and movement of human neutrophils. J. Cell Sci. 88 Pt 3 (1987) 399-406
69. Samuelsson B., Dahlen S.E., Lindgren J.A., Rouzer C.A., and Serhan C.N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237 (1987) 1171-1176
70. Sengelov H., Kjeldsen L., Diamond M.S., Springer T.A., and Borregaard N. Subcellular localization and dynamics of Mac-1 (alpham beta 2) in human neutrophils. J. Clin. Invest. 92 (1993) 1467-1476
71. Simchowitz L., Atkinson J.P., and Spilberg I. Stimulus-specific deactivation of chemotactic factor-induced cyclic AMP response and superoxide generation by human neutrophils. J. Clin. Invest. 66 (1980) 736-747
72. Spada C.S., Nieves A.L., Krauss A.H., and Woodward D.F. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J. Leukoc. Biol. 55 (1994) 183-191
73. Steel H.C., Tintinger G.R., Theron A.J., and Anderson R. Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B(4). Clin. Exp. Immunol. (2007)
74. Stokoe D., Caudwell B., Cohen P.T., and Cohen P. The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. Biochem. J. 296 Pt 3 (1993) 843-849
75. Suzuki K., Hino M., Hato F., Tatsumi N., and Kitagawa S. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. Blood 93 (1999) 341-349
76. Suzuki K., Hino M., Kutsuna H., Hato F., Sakamoto C., Takahashi T., Tatsumi N., and Kitagawa S. Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1beta. J. Immunol. 167 (2001) 5940-5947
77. Van Eps A.W., and Pollitt C.C. Equine laminitis induced with oligofructose. Equine Vet. J. 38 (2006) 203-208
78. von Andrian U.H., Chambers J.D., McEvoy L.M., Bargatze R.F., Arfors K.E., and Butcher E.C. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7538-7542
79. Waguespack R.W., Cochran A., and Belknap J.K. Expression of the cyclooxygenase isoforms in the prodromal stage of black walnut-induced laminitis in horses. Am. J. Vet. Res. 65 (2004) 1724-1729
80. Weber C., and Springer T.A. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J. Clin. Invest. 100 (1997) 2085-2093
81. Weiss D.J., Geor R.J., Johnston G., and Trent A.M. Microvascular thrombosis associated with onset of acute laminitis in ponies. Am. J. Vet. Res. 55 (1994) 606-612
82. Weiss D.J., Trent A.M., and Johnston G. Prothrombotic events in the prodromal stages of acute laminitis in horses. Am. J. Vet. Res. 56 (1995) 986-991
83. Weiss D.J., Monreal L., Angles A.M., and Monasterio J. Evaluation of thrombin-antithrombin complexes and fibrin fragment D in carbohydrate-induced acute laminitis. Res. Vet. Sci. 61 (1996) 157-159
84. Weiss D.J., Evanson O.A., McClenahan D., Fagliari J.J., Dunnwiddie C.T., and Wells R.E. Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies. Am. J. Vet. Res. 59 (1998) 814-817
85. Wong C.K., Cheung P.F., Ip W.K., and Lam C.W. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am. J. Respir. Cell Mol. Biol. 37 (2007) 85-96
86. Wright S.D., Rao P.E., Wesley C., van Voorhis W.C., Craigmyle L.S., Iida K., Talle M.A., Westberg E.F., Goldstein G., and Silverstein S.C. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 5699-5703
87. Wu Y., Zhan L., Ai Y., Hannigan M., Gaestel M., Huang C.K., and Madri J.A. MAPKAPK2-mediated LSP1 phosphorylation and FMLP-induced neutrophil polarization. Biochem. Biophys. Res. Commun. 358 (2007) 170-175
88. Zanin-Zhorov A., Tal-Lapidot G., Cahalon L., Cohen-Sfady M., Pevsner-Fischer M., Lider O., and Cohen I.R. Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J. Immunol. 179 (2007) 41-44
89. Zarbock A., Polanowska-Grabowska R.K., and Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 21 (2007) 99-111
90. Zu Y.L., Qi J., Gilchrist A., Fernandez G.A., Vazquez-Abad D., Kreutzer D.L., Huang C.K., and Sháafi R.I. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. J. Immunol. 160 (1998) 1982-1989